logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Inivata Ltd.

Calculating rank
USPTO Granted Patents = 19


Trademarks = 8

Forward Citations = 19

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Tim Forshew (15 out of 15 patents)

silverMedal Samuel Woodhouse (14 out of 17 patents)

bronzeMedal Vincent Plagnol (12 out of 12 patents)

4.  Stefanie Viola Lensing (11 out of 11 patents)

5.  Matthew Edward Smith (6 out of 6 patents)

6.  Karen Howarth (3 out of 3 patents)

7.  Michael Epstein (3 out of 3 patents)

8.  Giovanni Marsico (3 out of 3 patents)

9.  Andrew Lawson (3 out of 3 patents)

10.  Clive Morris (2 out of 2 patents)

11.  John Beeler (2 out of 2 patents)

12.  Greg Jones (2 out of 2 patents)


19 patents:

1. 12516370 - METHODS FOR LABELLING NUCLEIC ACIDS (2026-01-06),
2. 12509733 - Methods and systems for detecting a primary disease (2025-12-30),
3. 12378595 - Method for the analysis of minimal residual disease (2025-08-05),
4. 12371744 - Method of sequencing a nucleic acid of interest (2025-07-29),
5. 12365940 - Methods of labelling nucleic acids using variable length oligonucleotides (2025-07-22),
6. 12247249 - Method for amplifying a genomic sample (2025-03-11),
7. 12195807 - Method of treating a cancer patient without the need for a tissue biopsy (2025-01-14),
8. 12163187 - Methods of sequencing nucleic acids and error correction of sequence reads (2024-12-10),
9. 12084724 - Computational method for detecting fusion events (2024-09-10),
10. 11788116 - Method for the analysis of minimal residual disease (2023-10-17),
11. 11674175 - Methods of labelling nucleic acids (2023-06-13),
12. 11566274 - Method for the analysis of minimal residual disease (2023-01-31),
13. 11377698 - Method of treating a cancer patient without the need for a tissue biopsy (2022-07-05),
14. 11359233 - Methods for labelling nucleic acids (2022-06-14),
15. 11186878 - Method for predicting and monitoring response to an immune checkpoint inhibitor (2021-11-30),
Company Overview
Inivata Ltd. is a biotechnology company based in Cambridge, UK, specializing in the development of innovative liquid biopsy solutions for cancer diagnostics. The company focuses on harnessing advanced genomic technologies to provide insights into tumor biology, enabling personalized treatment strategies for patients. By leveraging its proprietary platform, Inivata aims to enhance the accuracy and efficiency of cancer detection and monitoring, contributing to the evolving landscape of precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#57 in Cambridge

#928 in United Kingdom

#32,705 in the World

Cambridge, GB
Cambridge, United Kingdom

Inivata Ltd.

Forward Citations = 19

12 inventors:

goldMedal Tim Forshew (15 out of 15 patents)

silverMedal Samuel Woodhouse (14 out of 17 patents)

bronzeMedal Vincent Plagnol (12 out of 12 patents)

4.  Stefanie Viola Lensing (11 out of 11 patents)

5.  Matthew Edward Smith (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inivata Ltd.. Retrieved from https://idiyas.com/company/inivata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…